Cerevel Therapeutics Holdings Stock Working Capital
Cerevel Therapeutics Holdings fundamentals help investors to digest information that contributes to Cerevel Therapeutics' financial success or failures. It also enables traders to predict the movement of Cerevel Stock. The fundamental analysis module provides a way to measure Cerevel Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cerevel Therapeutics stock.
Cerevel |
Cerevel Therapeutics Holdings Company Working Capital Analysis
Cerevel Therapeutics' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Cerevel Therapeutics Working Capital | 914.76 M |
Most of Cerevel Therapeutics' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cerevel Therapeutics Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionIn accordance with the company's disclosures, Cerevel Therapeutics Holdings has a Working Capital of 914.76 M. This is 114.91% higher than that of the Biotechnology sector and 69.83% higher than that of the Health Care industry. The working capital for all United States stocks is 38.12% higher than that of the company.
Cerevel Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cerevel Therapeutics' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cerevel Therapeutics could also be used in its relative valuation, which is a method of valuing Cerevel Therapeutics by comparing valuation metrics of similar companies.Cerevel Therapeutics is currently under evaluation in working capital category among its peers.
Cerevel Fundamentals
| Return On Equity | -0.92 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | 7.71 B | |||
| Shares Outstanding | 182.2 M | |||
| Shares Owned By Insiders | 15.32 % | |||
| Shares Owned By Institutions | 85.12 % | |||
| Number Of Shares Shorted | 5.98 M | |||
| Price To Earning | (0.26) X | |||
| Price To Book | 14.51 X | |||
| EBITDA | (441.64 M) | |||
| Net Income | (432.84 M) | |||
| Cash And Equivalents | 531.21 M | |||
| Cash Per Share | 3.58 X | |||
| Total Debt | 480.78 M | |||
| Debt To Equity | 0.20 % | |||
| Current Ratio | 9.52 X | |||
| Book Value Per Share | 3.10 X | |||
| Cash Flow From Operations | (342.3 M) | |||
| Short Ratio | 2.37 X | |||
| Earnings Per Share | (2.73) X | |||
| Target Price | 43.4 | |||
| Number Of Employees | 355 | |||
| Beta | 1.41 | |||
| Market Capitalization | 8.19 B | |||
| Total Asset | 1.24 B | |||
| Retained Earnings | (1.4 B) | |||
| Working Capital | 914.76 M | |||
| Current Asset | 9.77 M | |||
| Current Liabilities | 5.22 M | |||
| Net Asset | 1.24 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Cerevel Stock
If you are still planning to invest in Cerevel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cerevel Therapeutics' history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |